The global bone cement & glue market is entering a period of steady and resilient growth, creating significant opportunities for healthcare executives, investors, and medtech innovators. Valued at US$1,549 million in 2022, the market grew to US$1,644 million in 2023 and is projected to advance at a CAGR of 6.5%, reaching US$2,248 million by 2028.

For C-level leaders, this market is more than a reflection of rising surgical demand—it is a strategic growth arena that blends demographic shifts, medical innovation, and geographic expansion. By understanding the driving forces, competitive dynamics, and regional leadership, executives can align investment and operational strategies to capture sustainable ROI.

Download PDF Brochure

Why the Bone Cement & Glue Market is Growing

Two primary factors underpin market expansion:

1. Rising surgical procedures – The global increase in orthopedic surgeries, especially total hip arthroplasty (THA) and total knee arthroplasty (TKA), is driving higher adoption of bone cement and glue products.
2. Growing road traffic accidents – In developing markets, rising accident cases have escalated the demand for orthopedic interventions, accelerating product utilization.

At the same time, challenges remain. High costs, product-related complications, and stringent clinical data requirements for new product approvals create barriers to rapid adoption. For executives, these risks underscore the importance of strategic partnerships, investment in innovation, and careful market entry planning.

Where Regional Markets Are Shaping Global Opportunities

The bone cement & glue market is not uniform—it is shaped by distinct regional dynamics that executives must understand to allocate resources effectively.

1. North America – Largest Market Share

• Drivers: High prevalence of target diseases, an aging population, and widespread awareness of advanced orthopedic treatments.
• Strategic Advantage: Well-established healthcare infrastructure and strong presence of market leaders such as Stryker, Zimmer Biomet, and DePuy Synthes (Johnson & Johnson).
• Executive Insight: Investments in advanced surgical capabilities by hospitals ensure consistent demand, making North America a safe and reliable market for expansion.

2. Europe – A Market of Diverging Growth Leaders

• France: Projected to hold the highest share due to a robust healthcare system, advanced medical technologies, and a skilled orthopedic workforce. The nation’s aging population further amplifies long-term demand.
• Germany: Expected to register the second-highest growth rate, supported by a large geriatric population, rising sports-related injuries, and intensive R&D activity. Strategic initiatives by local players also accelerate growth.
• Executive Insight: France and Germany represent not only revenue opportunities but also innovation hubs for orthopedic technologies, positioning Europe as a critical R&D and adoption market.

3. Asia Pacific – High Growth with China in the Lead

• China: Dominates the region with rapid economic growth, high orthopedic case volume, increasing road accidents, and strong government support.
• Other APAC regions: India and Japan are showing increased adoption of orthopedic solutions, though China’s sheer scale positions it as the regional growth anchor.
• Executive Insight: For multinationals, China offers both market scale and policy-driven incentives, making it an essential market for long-term expansion.

4. Rest of the World

• Emerging regions are contributing to steady demand, particularly in Latin America and the Middle East, where healthcare modernization is underway.

When Hospitals and Ambulatory Surgical Centers Lead End-User Growth

The hospitals and ambulatory surgical centers (ASCs) segment represents the fastest-growing end-user category within the bone cement & glue market. Several factors drive this trend:

• High surgical volume: Hospitals and ASCs are primary providers of THA and TKA, both major applications of bone cement and glue.
• Demographic shifts: The aging population globally is more likely to require orthopedic surgeries.
• Infrastructure investments: Many hospitals are upgrading surgical capabilities to meet rising demand for orthopedic and trauma care.

Executive Insight: By aligning commercial strategies with hospitals and ASC networks, medtech companies can secure high-volume contracts, improve brand penetration, and ensure consistent demand streams.

Who the Key Players Are and How They Shape Market Dynamics

The bone cement & glue market is dominated by established multinational players with strong R&D pipelines and extensive distribution networks:

• Stryker (US)
• Zimmer Biomet (US)
• DePuy Synthes (Johnson & Johnson, US)
• Enovis (US)
• Heraeus Holding (Germany)
• Medtronic (Ireland)

These companies drive market innovation through new product launches, mergers & acquisitions, and strategic collaborations. Their competitive advantage lies in offering integrated solutions—combining bone cement products with surgical instruments and implants—to provide end-to-end value for hospitals and surgeons.

Request Sample Report

What Strategic Opportunities Executives Should Focus On

For senior leaders evaluating the bone cement & glue industry, several actionable opportunities stand out:

1. Invest in Emerging Markets – With China and France showing outsized growth potential, targeted investments in these regions will deliver above-average returns.
2. Capitalize on Aging Demographics – Strategic positioning around geriatric-focused solutions will ensure consistent demand for orthopedic products.
3. Expand ASC Partnerships – As ASCs continue to grow, partnerships with these facilities represent a scalable and cost-effective distribution model.
4. R&D for Safety and Efficacy – Addressing product complications and improving formulations can provide competitive differentiation and smoother regulatory approvals.
5. Digital Integration in Orthopedic Care – Incorporating digital surgery solutions, AI-driven surgical planning, and robotic-assisted procedures will enhance the adoption of bone cement and glue products.

Conclusion: The Bone Cement & Glue Market as a Strategic Growth Catalyst

The global bone cement & glue market is not just expanding—it is evolving. With North America leading in scale, France and Germany reshaping Europe’s orthopedic landscape, China anchoring Asia Pacific growth, and hospitals/ASCs driving demand, the market presents diverse and high-value opportunities for C-level executives. For medtech and healthcare leaders, the strategic question is not if but how to invest in this market. By focusing on innovation, regional expansion, and strategic partnerships, executives can capture sustainable ROI while contributing to improved orthopedic care worldwide.